Recombinant Human Endostatin (Endostar) Combined with Concurrent Intensity Modulated Radiation Therapy for Elderly Local Advanced NSCLC

被引:0
|
作者
Chen, Q. [1 ]
Xie, Q. [2 ]
Shi, Q. [2 ]
机构
[1] Fuzhou Pulm Hosp Fujian, Oncol, Fuzhou, Fujian, Peoples R China
[2] Fuzhou Pulm Hosp Fujian, Fuzhou, Fujian, Peoples R China
关键词
Endostar; IMRT; elderly NSCLC;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.14-011
引用
收藏
页码:S2178 / S2178
页数:1
相关论文
共 50 条
  • [1] Envafolimab Combined with Recombinant Human Endostatin and Chemotherapy for NSCLC
    Miao, C.
    Yuan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S397 - S397
  • [2] Continuous Intravenous Recombinant Human Endostatin Pump Combined with SBRT for Elderly Patients with Early Stage NSCLC
    Zhang, L.
    Peng, P.
    Chen, Y.
    Li, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1091 - S1091
  • [3] Envafolimab Combined with Recombinant Human Endostatin and Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC
    Liu, L.
    Liu, J.
    Liu, Y.
    Yu, X.
    Li, S.
    Li, B.
    Guo, S.
    Zhang, Y.
    Wang, Y.
    Zheng, T.
    Han, W.
    Xie, Y.
    Zhou, L.
    Zhang, J.
    Zhao, Y.
    Li, Y.
    Hu, Y.
    Wang, J.
    Cao, H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S397 - S397
  • [4] Research About Different Administration Mode of Endostar for Combining with Concurrent Chemoradiotherapy in Local Advanced NSCLC
    Li, J.
    Qiu, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2337 - S2337
  • [5] Outcome of Intensity Modulated Radiation Therapy Combined With Concurrent Chemotherapy for Recurrent Nasopharyngeal Carcinoma
    Lu, H.
    Ding, X.
    Yu, J.
    Chen, X.
    Li, X. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S490 - S490
  • [6] Recombinant human endostatin injection (Endostar) combined with PF chemotherapy and sequential intensity-modulated radiotherapy is tolerable and improves prognosis of locally advanced nasopharyngeal carcinoma: a randomized, open, multicenter phase II clinical study
    Xu, Lu
    Li, Dailong
    Ji, Jinxing
    Chen, Zhuo
    Tang, Xi
    Chen, Dian
    Li, Xin
    Bao, Dan
    Yan, Fan
    Pang, Yaqi
    Liu, Siqi
    Zhou, Yunfeng
    Xu, Xinhua
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (10): : 4622 - 4636
  • [7] The Role of Concurrent Chemoradiation Therapy for Locally Advanced Nasopharyngeal Carcinoma in the Era of Intensity Modulated Radiation Therapy
    Yi, J.
    Gao, L.
    Huang, X.
    Luo, J.
    Wang, K.
    Xu, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S483 - S483
  • [8] Evaluation of endocrine therapy combined with intensity modulated radiation therapy in patients with advanced prostate cancer
    Xiulong Ma
    Hongbing Ma
    Dongli Ruan
    OncologyandTranslationalMedicine, 2021, 7 (05) : 229 - 234
  • [9] Intensity Modulated Radiation Therapy or 3D Conformal Radiation Therapy Combined with Brachytherapy and Concurrent Chemoradiotherapy in Advanced Cervical Cancer: A Retrospective Multicenter Study
    Yan, J.
    Wei, L.
    He, J.
    Wang, T.
    Ran, L.
    Zou, L.
    Li, X.
    Zhao, F.
    Zi, L.
    Li, S.
    Sun, X.
    Zhong, W.
    Gao, Y.
    Dong, M.
    Gao, K.
    Cheng, G.
    Sun, B.
    Zhang, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E638 - E639
  • [10] Intensity Modulated Radiation Therapy and Concurrent Chemotherapy for Locally Advanced Cervical Cancer Not Amenable to Brachytherapy
    Pachigolla, S. L.
    Markovina, S.
    Lin, A. J.
    Schwarz, J. K.
    Grigsby, P. W.
    Badiyan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E620 - E620